Clinical trial
Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With…
NCT00084708 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00084708 |
|---|---|
| Title | Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors |
| Official title | A Phase I Study of Intravenous (IV) Calcitriol in Combination With ZD1839 (IRESSA®) in Refractory Solid Tumors |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Dietary Supplement, Drug |
| Interventions | calcitriol, dexamethasone, gefitinib |
| Enrollment | 53 |
| Start date | Nov 1, 2002 |
| Primary completion | Oct 1, 2006 |
| Completion | May 1, 2007 |
| First posted | Jun 11, 2004 |
| Last update posted | Jan 13, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: